abstract |
Described is a solid preparation, containing 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, which is suitable for use in the treatment of immunological conditions. |